HUMAW

Humacyte Inc

• TipRanks·2d ago

  Largest borrow rate increases among liquid names

• TipRanks·2d ago

  High-Profile Director Makes Bold Move Into Humacyte Shares

• PUBT·2d ago

  Humacyte director Kathleen Sebelius acquires 56,818 shares for $49,999.84

• PUBT·2d ago

  Humacyte director Michael T. Constantino acquires common shares worth $9,840

• TipRanks·3d ago

  Humacyte reports Symvess under contract with Strategic Acquisition Center of VA

• PUBT·3d ago

  Humacyte Symvess wins U.S. Veterans Affairs Strategic Acquisition Center contract

• Benzinga·3d ago

  Humacyte Says Symvess Is Now Under Contract With Strategic Acquisition Center Of US Department Of Veterans Affairs

• Reuters·3d ago

  HUMACYTE ANNOUNCES SYMVESS® IS NOW UNDER CONTRACT WITH THE STRATEGIC ACQUISITION CENTER (SAC) OF THE U.S. DEPARTMENT OF VETERANS AFFAIRS

• Dow Jones·3d ago

  Press Release: Humacyte Announces Symvess(R) is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

• Simply Wall St·6d ago

  Humacyte (HUMA) Valuation Check As Q1 2026 Losses Meet Cost Cuts New Leadership And Global Agreements

• Dow Jones·05/14 15:00

  Humacyte Price Target Raised to $1.50/Share From $1.00 by TD Cowen

• Dow Jones·05/14 15:00

  Humacyte Is Maintained at Buy by TD Cowen

• Benzinga·05/14 14:49

  TD Cowen Maintains Buy on Humacyte, Raises Price Target to $1.5

• Simply Wall St·05/14 12:45

  Does Humacyte’s (HUMA) Nasdaq Notice Quietly Reframe Its Financing Flexibility And Clinical Adoption Story?

• TipRanks·05/14 11:21

  Piper Sandler Keeps Their Hold Rating on Humacyte (HUMA)